Jci_page_head_homepage_01 Jci_page_head_homepage_02
Tetsushi Sadakata, Miwa Washida, Yoshimi Iwayama, Satoshi Shoji, Yumi Sato, Takeshi Ohkura, Ritsuko Katoh-Semba, Mizuho Nakajima, Yukiko Sekine, Mika Tanaka, Kazuhiko Nakamura, Yasuhide Iwata, Kenji J. Tsuchiya, Norio Mori, Sevilla D. Detera-Wadleigh, Hironobu Ichikawa, Shigeyoshi Itohara, Takeo Yoshikawa, Teiichi Furuichi
Published in Volume 117, Issue 4
J Clin Invest. 2007; 117(4):931–943 doi:10.1172/JCI29031
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 6
Abnormal immunohistochemical findings in the Cadps2–/– mouse hippocampus.

(AC) Sagittal sections of the P8 hippocampus immunostained for CADPS2 (green in A) and BDNF (red in B). A merged image is shown in C. Scale bar: 200 μm. (DF) Higher magnification of the region shown by the square in A. s.p., stratum pyramidale; s.l., stratum lucidum; s.r., stratum radiatum. Scale bar: 10 μm. (GJ) Sagittal sections of WT (G) and Cadps2–/– (HJ) P17 hippocampus immunostained for parvalbumin. (I and J) Sections were prepared from P17 Cadps2–/– mice 12 days after an icv injection of either vehicle (I) or BDNF (J). Scale bars: 500 μm. (K) Cell density of parvalbumin-positive neurons in the P17 hippocampus. The error bars indicate SD. **P < 0.01, Student’s t test.